Cancer care: Long battle for affordable treatment
The Hindu
Advances in oncology have improved treatment options, but their benefits
remain out of reach for many patients who cannot afford to complete the
prescribed course. This is despite the recent decision to cap trade margins on
137 identified non-scheduled anti-cancer medicines, providing some relief,
writes Afshan Yasmeen...





